The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Epithelial–mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Dissemination and growth of cancer cells in metastatic sites
Chambers, A. F., Groom, A. C., & MacDonald, I. C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc865 · Cited by 3,911
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855
Cano, A., Pérez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F., & Nieto, M. A. (2000) · Nature Cell Biology · doi:10.1038/35000025 · Cited by 3,668
High Frequency of Mutations of the PIK3CA Gene in Human Cancers
Samuels, Y., Wang, Z., Bardelli, A., Silliman, N., Ptak, J., Szabo, S., Yan, H., Gazdar, A., Powell, S. M., Riggins, G. J., et al. (2004) · Science · doi:10.1126/science.1096502 · Cited by 3,437
Batlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J., & García de Herreros, A. (2000) · Nature Cell Biology · doi:10.1038/35000034 · Cited by 2,666
Addiction to Oncogenes--the Achilles Heal of Cancer
Weinstein, I. B. (2002) · Science · doi:10.1126/science.1073096 · Cited by 1,728
Vleminckx, K., Vakaet, L., Mareel, M., Fiers, W., & Van Roy, F. (1991) · Cell · doi:10.1016/0092-8674(91)90143-m · Cited by 1,656 · cited 1×
“E-cadherin is considered to act as a tumor suppressor for two main reasons: transcription of its gene is silenced in various carcinomas, and reexpression of a native form of E-cadherin in carcinomas in vitro is sufficient to reduce the aggressiveness of tumor cells (Vleminckx et al., 1991).”
BackgroundE-cadherin germline mutations in familial gastric cancer
Guilford, P., Hopkins, J., Harraway, J., McLeod, M., McLeod, N., Harawira, P., Taite, H., Scoular, R., Miller, A., & Reeve, A. E. (1998) · Nature · doi:10.1038/32918 · Cited by 1,656
Epithelial-Mesenchymal Transitions
Kang, Y., & Massagué, J. (2004) · Cell · doi:10.1016/j.cell.2004.07.011 · Cited by 1,525
Cited by
Signaling mechanisms of the epithelial-mesenchymal transition
Gonzalez, D. M., & Medici, D. (2014) · Science Signaling · doi:10.1126/scisignal.2005189 · Cited by 1,721
Perturbations of the AKT signaling pathway in human cancer
Altomare, D. A., & Testa, J. R. (2005) · Oncogene · doi:10.1038/sj.onc.1209085 · Cited by 1,329
On the Origin of Cancer Metastasis
Seyfried, T. N., & Huysentruyt, L. C. (2013) · Critical Reviews in Oncogenesis · doi:10.1615/critrevoncog.v18.i1-2.40 · Cited by 1,196
Current development of mTOR inhibitors as anticancer agents
Faivre, S., Kroemer, G., & Raymond, E. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2062 · Cited by 1,000
Sever, R., & Brugge, J. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006098 · Cited by 989
Brain metastases: epidemiology and pathophysiology
Gavrilovic, I. T., & Posner, J. B. (2005) · Journal of Neuro-Oncology · doi:10.1007/s11060-004-8093-6 · Cited by 975
Zhang, X., Wang, S., Wang, H., Cao, J., Huang, X., Chen, Z., Xu, P., Sun, G., Xu, J., Lv, J., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-018-0935-5 · Cited by 842
RetractedEpithelial-mesenchymal transition in cancer development and its clinical significance
Iwatsuki, M., Mimori, K., Yokobori, T., Ishi, H., Beppu, T., Nakamori, S., Baba, H., & Mori, M. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2009.01419.x · Cited by 780
Moustakas, A., & Heldin, C. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00550.x · Cited by 804
Metastasis: recent discoveries and novel treatment strategies
Eccles, S. A., & Welch, D. R. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60781-8 · Cited by 721
Brown, R. L., Reinke, L. M., Damerow, M. S., Perez, D., Chodosh, L. A., Yang, J., & Cheng, C. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44540 · Cited by 631
To differentiate or not — routes towards metastasis
Brabletz, T. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3265 · Cited by 623
Causes and Consequences of Increased Glucose Metabolism of Cancers
Gillies, R. J., Robey, I., & Gatenby, R. A. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.047258 · Cited by 623
Chapter 2 PI3K/PTEN Signaling in Angiogenesis and Tumorigenesis
(2009) · Advances in Cancer Research · doi:10.1016/s0065-230x(09)02002-8 · Cited by 620
“PI3K and AKT also increase invasiveness and downregulate E-cadherin expression (Grille et al., 2003; Larue and Bellacosa, 2005; Schramek et al., 2003; Thiery and Sleeman, 2006).”
BackgroundWang, Z., Li, Y., Kong, D., Banerjee, S., Ahmad, A., Azmi, A. S., Ali, S., Abbruzzese, J. L., Gallick, G. E., & Sarkar, F. H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4312 · Cited by 619
Regulation and function of miRNA-21 in health and disease
Kumarswamy, R., Volkmann, I., & Thum, T. (2011) · RNA Biology · doi:10.4161/rna.8.5.16154 · Cited by 607
Rice, A. J., Cortes, E., Lachowski, D., Cheung, B. C. H., Karim, S. A., Morton, J. P., & del Río Hernández, A. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.54 · Cited by 523
Molecular Pathogenesis of Oral Squamous Cell Carcinoma: Implications for Therapy
Choi, S., & Myers, J. N. (2008) · Journal of Dental Research · doi:10.1177/154405910808700104 · Cited by 516
Ferretti, C., Bruni, L., Dangles-Marie, V., Pecking, A. P., & Bellet, D. (2006) · Human Reproduction Update · doi:10.1093/humupd/dml048 · Cited by 509
Cross-talk between mitogenic Ras/MAPK and survival PI3K/Akt pathways: a fine balance
Aksamitiene, E., Kiyatkin, A., & Kholodenko, B. N. (2012) · Biochemical Society Transactions · doi:10.1042/bst20110609 · Cited by 479
“Activation of Akt stimulates angiogenesis and induces epithelial-mesenchymal transition characterized by the morphological changes, production of metalloproteinases, loss of cell-to-cell adhesion and increased invasive cell migration [3, 16-17].”
BackgroundActivation of NF-κB by Akt upregulates Snail expression and induces epithelium mesenchyme transition
Julien, S., Puig, I., Caretti, E., Bonaventure, J., Nelles, L., van Roy, F., Dargemont, C., de Herreros, A. G., Bellacosa, A., & Larue, L. (2007) · Oncogene · doi:10.1038/sj.onc.1210546 · Cited by 476
Self-citationSong, L.-B., Li, J., Liao, W.-T., Feng, Y., Yu, C.-P., Hu, L.-J., Kong, Q.-L., Xu, L.-H., Zhang, X., Liu, W.-L., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39374 · Cited by 398
The Dual Role of TGFβ in Human Cancer: From Tumor Suppression to Cancer Metastasis
Neel, J.-C., Humbert, L., & Lebrun, J.-J. (2012) · ISRN Molecular Biology · doi:10.5402/2012/381428 · Cited by 345
Epithelial-mesenchymal Transition and Cell Invasion
Son, H.-J., & Moon, A. (2010) · Toxicological Research · doi:10.5487/tr.2010.26.4.245 · Cited by 320
Wu, R., Hendrix-Lucas, N., Kuick, R., Zhai, Y., Schwartz, D. R., Akyol, A., Hanash, S., Misek, D. E., Katabuchi, H., Williams, B. O., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.02.016 · Cited by 313
The phosphatidyl inositol 3-kinase signaling network: implications for human breast cancer
Dillon, R. L., White, D. E., & Muller, W. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210202 · Cited by 311
Fuchs, B. C., Fujii, T., Dorfman, J. D., Goodwin, J. M., Zhu, A. X., Lanuti, M., & Tanabe, K. K. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2460 · Cited by 309
Redox mechanisms switch on hypoxia-dependent epithelial–mesenchymal transition in cancer cells
Cannito, S., Novo, E., Compagnone, A., Valfrè di Bonzo, L., Busletta, C., Zamara, E., Paternostro, C., Povero, D., Bandino, A., Bozzo, F., et al. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn216 · Cited by 309
Byles, V, Zhu, L., Lovaas, J. D., Chmilewski, L. K., Wang, J., Faller, D. V., & Dai, Y. (2012) · Oncogene · doi:10.1038/onc.2011.612 · Cited by 309
Azab, A. K., Hu, J., Quang, P., Azab, F., Pitsillides, C., Awwad, R., Thompson, B., Maiso, P., Sun, J. D., Hart, C. P., et al. (2012) · Blood · doi:10.1182/blood-2011-09-380410 · Cited by 301
Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming
Mattioli, R., Ilari, A., Colotti, B., Mosca, L., Fazi, F., & Colotti, G. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101205 · Cited by 294
(1926) · The American Journal of Surgery · doi:10.1016/s0002-9610(26)90068-8 · Cited by 293
Kumarswamy, R., Volkmann, I., Jazbutyte, V., Dangwal, S., Park, D.-H., & Thum, T. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.234286 · Cited by 293
The Regulatory Role of MicroRNAs in EMT and Cancer
Zaravinos, A. (2015) · Journal of Oncology · doi:10.1155/2015/865816 · Cited by 291
Alsuliman, A., Colak, D., Al-Harazi, O., Fitwi, H., Tulbah, A., Al-Tweigeri, T., Al-Alwan, M., & Ghebeh, H. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0421-2 · Cited by 285
Bhat, G. R., Sethi, I., Sadida, H. Q., Rah, B., Mir, R., Algehainy, N., Albalawi, I. A., Masoodi, T., Subbaraj, G. K., Jamal, F., et al. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-024-10172-z · Cited by 281
Yoshimoto, M., Joshua, A. M., Cunha, I. W., Coudry, R. A., Fonseca, F. P., Ludkovski, O., Zielenska, M., Soares, F. A., & Squire, J. A. (2008) · Modern Pathology · doi:10.1038/modpathol.2008.96 · Cited by 279
The extracellular matrix: At the center of it all
Bowers, S. L. K., Banerjee, I., & Baudino, T. A. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.08.024 · Cited by 277
Lysyl Oxidase, Extracellular Matrix Remodeling and Cancer Metastasis
Xiao, Q., & Ge, G. (2012) · Cancer Microenvironment · doi:10.1007/s12307-012-0105-z · Cited by 276
Wang, H., Wang, H.-S., Zhou, B.-H., Li, C.-L., Zhang, F., Wang, X.-F., Zhang, G., Bu, X.-Z., Cai, S.-H., & Du, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056664 · Cited by 273
Epithelial-Mesenchymal Transition in tumor microenvironment
Jing, Y., Han, Z., Zhang, S., Liu, Y., & Wei, L. (2011) · Cell & Bioscience · doi:10.1186/2045-3701-1-29 · Cited by 270
Soltermann, A., Tischler, V., Arbogast, S., Braun, J., Probst-Hensch, N., Weder, W., Moch, H., & Kristiansen, G. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0935 · Cited by 269
3D Bioprinted in vitro metastatic models via reconstruction of tumor microenvironments
Meng, F., Meyer, C. M., Joung, D., Vallera, D. A., McAlpine, M. C., & Panoskaltsis‐Mortari, A. (2019) · Advanced Materials · doi:10.1002/adma.201806899 · Cited by 262
Fibroblast activation and myofibroblast generation in obstructive nephropathy
Grande, M. T., & López-Novoa, J. M. (2009) · Nature Reviews Nephrology · doi:10.1038/nrneph.2009.74 · Cited by 265
Das, V., Bhattacharya, S., Chikkaputtaiah, C., Hazra, S., & Pal, M. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28160 · Cited by 263
Dietary flavonoids: Role of (−)-epicatechin and related procyanidins in cell signaling
Fraga, C. G., & Oteiza, P. I. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.06.002 · Cited by 257
Turley, E. A., Veiseh, M., Radisky, D. C., & Bissell, M. J. (2008) · Nature Clinical Practice Oncology · doi:10.1038/ncponc1089 · Cited by 253
uPAR induces epithelial–mesenchymal transition in hypoxic breast cancer cells
Lester, R. D., Jo, M., Montel, V., Takimoto, S., & Gonias, S. L. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200701092 · Cited by 253
Cannito, S., Novo, E., di Bonzo, L. V., Busletta, C., Colombatto, S., & Parola, M. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2737 · Cited by 239
“However, PI3K activation is also considered a major molecular effector of EMT (138) since, through Akt, can phosphorylate and inactivate GSK-3b.”
Jing, Y.-Y., Han, Z.-P., Sun, K., Zhang, S.-S., Hou, J., Liu, Y., Li, R., Gao, L., Zhao, X., Zhao, Q.-D., et al. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-98 · Cited by 162
“Epithelial to mesenchymal transition (EMT) is a process in which epithelial cell layers lose polarity together with cell to cell contacts which results in a dramatic remodeling of the cytoskeleton, and has an important role in tumor metastasis [17].”
BackgroundCancer-associated fibroblasts enact field cancerization by promoting extratumoral oxidative stress
Chan, J. S. K., Tan, M. J., Sng, M. K., Teo, Z., Phua, T., Choo, C. C., LI, L., Zhu, P., & Tan, N. S. (2017) · Cell Death & Disease · doi:10.1038/cddis.2016.492 · Cited by 130
Mouse Snail Is a Target Gene for HIF
Luo, D., Wang, J., Li, J., & Post, M. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0214 · Cited by 116
“Other signaling pathways implicated in EMT, including Wnt and phosphoinositide 3-kinase (15, 16), use GSK-3 to mediate their responses.”
BackgroundA Single-Base Substitution in the Seed Region of miR-184 Causes EDICT Syndrome
Iliff, B. W., Riazuddin, S. A., & Gottsch, J. D. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.11-8783 · Cited by 108
The tale of transforming growth factor‐beta (TGFβ) signaling: A soigné enigma
Chaudhury, A., & Howe, P. H. (2009) · IUBMB Life · doi:10.1002/iub.239 · Cited by 105
Amyloid-β precursor protein promotes cell proliferation and motility of advanced breast cancer
Lim, S., Yoo, B. K., Kim, H.-S., Gilmore, H. L., Lee, Y., Lee, H.-P., Kim, S.-J., Letterio, J., & Lee, H.-G. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-928 · Cited by 100
Epithelial-mesenchymal transition in chronic liver disease: fibrogenesis or escape from death?
Pinzani, M. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.02.001 · Cited by 86
“Activation of the phosphatidylinositol 3’ kinase (PI3K)/AKT axis is also emerging as a central feature of EMT [5].”
BackgroundTranscriptional Repression of E-Cadherin by Human Papillomavirus Type 16 E6
D'Costa, Z. J., Jolly, C., Androphy, E. J., Mercer, A., Matthews, C. M., & Hibma, M. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048954 · Cited by 83
Wei, R., Cortez Penso, N. E., Hackman, R. M., Wang, Y., & Mackenzie, G. G. (2019) · Nutrients · doi:10.3390/nu11081856 · Cited by 78
Buchanan, P. C., Boylan, K. L. M., Walcheck, B., Heinze, R., Geller, M. A., Argenta, P. A., & Skubitz, A. P. N. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.746859 · Cited by 73
Wang, L., Tian, Z., Yang, Q., Li, H., Guan, H., Shi, B., Hou, P., & Ji, M. (2015) · Oncotarget · doi:10.18632/oncotarget.4542 · Cited by 69
Hatipoglu, O. F., Uctepe, E., Opoku, G., Wake, H., Ikemura, K., Ohtsuki, T., Inagaki, J., Gunduz, M., Gunduz, E., Watanabe, S., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111633 · Cited by 67
Byeon, H. K., Na, H. J., Yang, Y. J., Ko, S., Yoon, S. O., Ku, M., Yang, J., Kim, J. W., Ban, M. J., Kim, J.-H., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.13480 · Cited by 29
Nanoparticle mediated alteration of EMT dynamics: an approach to modulate cancer therapeutics
Sen, P., Saha, M., & Ghosh, S. S. (2020) · Materials Advances · doi:10.1039/d0ma00455c · Cited by 21
Allegra, A., Casciaro, M., Barone, P., Musolino, C., & Gangemi, S. (2022) · Cancers · doi:10.3390/cancers14112597 · Cited by 19
Metadata
- Authors
- Larue, L., & Bellacosa, A.
- Venue
- Oncogene
- Published
- 2005-11-14
- Volume
- 24
- Issue
- 50
- Pages
- 7443-7454
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1973890143
- Cited by
- 1,228
- References
- 93
- FWCI
- 17.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.